Medicine and Dentistry
Patient
100%
Biological Marker
100%
Hospital
100%
COVID-19
100%
Prospective Cohort Study
100%
Virus Nucleocapsid
100%
Antigen
66%
C Reactive Protein
55%
Interleukin 6
44%
Hazard Ratio
33%
Antibodies
33%
Association
22%
Mortality
22%
Chronic Kidney Disease
22%
D-Dimer
22%
Therapeutics
22%
Health
11%
Therapeutic Procedure
11%
Marker
11%
Analysis
11%
Age
11%
Pathogenesis
11%
Follow up
11%
Inpatient
11%
Prognosis
11%
Infection
11%
Male
11%
Female
11%
Anti-Inflammatory Drug
11%
Vaccine
11%
Adjustment
11%
Virus Replication
11%
Antivirus Agent
11%
Severe Acute Respiratory Syndrome Coronavirus 2
11%
All Cause Mortality
11%
Inflammation
11%
Placebo
11%
Monoclonal Antibody
11%
Immune Dysregulation
11%
Comorbidity
11%
Measurement
11%
Pharmacology, Toxicology and Pharmaceutical Science
Prospective Cohort Study
100%
Biological Marker
100%
Antigen
100%
C Reactive Protein
83%
Interleukin 6
66%
Antibodies
50%
Mortality
33%
Chronic Kidney Failure
33%
D Dimer
33%
Anti-Inflammatory Drug
16%
Infection
16%
Prognosis
16%
Vaccine
16%
Placebo
16%
All Cause Mortality
16%
Antivirus Agent
16%
SARS Coronavirus
16%
Inflammation
16%
Pathogenesis
16%
Monoclonal Antibody
16%
Immune Dysregulation
16%
Comorbidity
16%
Immunology and Microbiology
COVID-19
100%
Virus Nucleocapsid
100%
Blood Plasma
66%
Antigen
66%
C-Reactive Protein
55%
Interleukin 6
44%
Immunology
33%
Antibodies
33%
Mortality
22%
Association
22%
Kidney
22%
Severe Acute Respiratory Syndrome Coronavirus 2
11%
Inflammation
11%
Viral Replication
11%
Viral Load
11%
Immune Dysregulation
11%
Age
11%
Health
11%
Monoclonal Antibody
11%
All Cause Mortality
11%
Vaccine
11%
Comorbidity
11%
Biochemistry, Genetics and Molecular Biology
Prospective Cohort Study
100%
Virus Nucleocapsid
100%
Blood Plasma
66%
C-Reactive Protein
55%
Interleukin 6
44%
Antibodies
33%
Mortality
22%
Association
22%
D-Dimer
22%
Age
11%
Health
11%
Immunity
11%
SARS Coronavirus
11%
Adjustment
11%
Virus Replication
11%
Virus Load
11%
All Cause Mortality
11%
Monoclonal Antibody
11%
Comorbidity
11%